Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Biochem Biophys ; 2010 Apr; 47(2): 90-95
Article Dans Anglais | IMSEAR | ID: sea-135249

Résumé

The mast cell-mediated allergic reactions are involved in many allergic diseases, such as asthma, allergic rhinitis and sinusitis. Stimulation of mast cells initiates the process of degranulation, resulting in the release of mediators such as histamine and an array of inflammatory cytokines. In this report, we investigated the effect of gossypin (a biflavonoid) and suramin (a synthetic polysulphonated naphtylurea) on the mast cell-mediated allergy model, and studied the possible mechanism of their action. Both gossypin and suramin inhibited (P<0.001) compound 48/80-induced systemic anaphylaxis reactions, antiprurities (P<0.001) and reduced the histamine release in rats. Further, both showed significant (P<0.001) protection against rat peritoneal mast cells activated by compound 48/80. Thus, our findings provide evidence that gossypin and suramin inhibit mast cell-derived allergic reactions.


Sujets)
Anaphylaxie/induit chimiquement , Anaphylaxie/traitement médicamenteux , Anaphylaxie/immunologie , Animaux , Antiallergiques/pharmacologie , Antiallergiques/usage thérapeutique , Antiprurigineux/pharmacologie , Antiprurigineux/usage thérapeutique , Liquide d'ascite/effets des médicaments et des substances chimiques , Liquide d'ascite/métabolisme , Liquide de lavage bronchoalvéolaire , Modèles animaux de maladie humaine , Flavonoïdes/pharmacologie , Flavonoïdes/usage thérapeutique , Libération d'histamine/effets des médicaments et des substances chimiques , Libération d'histamine/immunologie , Hypersensibilité/sang , Hypersensibilité/traitement médicamenteux , Hypersensibilité/immunologie , Hypersensibilité/métabolisme , Mastocytes/effets des médicaments et des substances chimiques , Mastocytes/immunologie , Mastocytes/métabolisme , Souris , Oxydes d'azote/sang , Oxydes d'azote/métabolisme , Rats , Suramine/pharmacologie , Suramine/usage thérapeutique , 4-Méthoxyphénéthyl-méthyl-amine/pharmacologie
2.
Indian J Med Microbiol ; 2006 Jan; 24(1): 72-4
Article Dans Anglais | IMSEAR | ID: sea-53604

Résumé

Human trypanosoma infections like the ones seen in Africa and South America are unknown in India. The only exception in literature is of two documented cases of a self-limiting febrile illness, being attributed to Trypanosoma lewisi like parasites. We are reporting an unusual case of trypanosomiasis from the rural parts of Chandrapur district in Maharashtra. An adult male farmhand who used to practice veterinary medicine also, presented with history of febrile episodes on and off since five months and drowsiness before admission to this Institute. Though routine blood and other investigations were within normal limits, the peripheral smear showed a large number of trypanosomes which morphologically resembled the species Trypanosoma evansi, the aetiological agent of surra - a form of animal trypanosomiasis. A battery of assays covering the spectrum of parasitology, serology, and molecular biology confirmed the infecting parasite to be T. evansi. Failure to demonstrate the central nervous system (CNS) involvement, as evidenced by the absence of parasite in cerebrospinal fluid (CSF) advocated the use of suramin - the drug of choice in early stage African trypanosomiasis without any CNS involvement. Suramin achieved cure in our patient. The case is being reported because of its unique nature as the patient was not immunocompromised and showed infestation with a parasite which normally does not affect human beings.


Sujets)
Animaux , ADN des protozoaires/analyse , Humains , Inde , Mâle , Adulte d'âge moyen , Réaction de polymérisation en chaîne , Suramine/usage thérapeutique , Trypanocides/usage thérapeutique , Trypanosoma/classification , Trypanosomiase/diagnostic
3.
São Paulo; s.n; 2003. [108] p. ilus, tab, graf.
Thèse Dans Portugais | LILACS | ID: lil-424871

Résumé

Avaliar o efeito do suramin na migração, proliferação e formação de tubo vascular em células endoteliais coroidianas (CECs) “in vitro” e em neovascularização coroidiana (NC) “in vivo”. Foi avaliada a migração através do experimento de Boyden Chamber. Foi avaliada a proliferação através do experimento MTT. Foi avaliada a formação de tubo vascular através do experimento gel colágeno 3D. As CECs foram estimuladas por fatores de crescimento (FC) e tratadas com suramin.O efeito sistêmico do suramin foi avaliado em NC induzidos por laser em olhos de ratos. O suramin inibiu a migração, proliferação e formação de tubo vascular estimulada por FC de forma dose dependente / This study evaluated the effects of suramin on choroidal endothelial cell (CEC) migration, proliferation and tube formation “in vitro” and choroidal neovascularization (CNV) “in vivo”. Migration was evaluated using Boyden chamber assay. Proliferation was evaluated by an MTT assay. Tube formation was evaluated using a 3D-tube formation assay. CECs were stimulated by growth factor (GF) treated with suramin. The effect of systemic administration of Suramin was evaluated on laser induced CNV in rats eyes. Suramin inhibited CEC migration, proliferation, and tube formation induced by GF in a dose dependent manner. CNV in rats was inhibited by systemic administration of Suramin 30mg/Kg. These studies indicate that suramin inhibits Angiogenesis “in vitro” and “in vivo”...


Sujets)
Techniques in vitro , Néovascularisation choroïdienne/anatomopathologie , Suramine/usage thérapeutique , Techniques de culture cellulaire/méthodes , Dégénérescence maculaire/anatomopathologie , Facteurs de croissance endothéliale/physiologie
4.
Arch. argent. dermatol ; 47(1): 31-41, ene.-feb. 1997. ilus
Article Dans Espagnol | LILACS | ID: lil-193272

Résumé

Se realiza una revisión del tema edema angioneurótico hereditario. Después de una introducción histórica se considera el sistema del complemento, el sistema de las cininas, los inhibidores de las proteasas hemáticas derivadas del plasminógeno y la vinculación entre ambos. Se consideran también los avances últimos en lo que a citogenética molecular se refiere. Se presentan las diferentes formas clínicas de los edemas angioneuróticos hereditarios, así como sus diferencias clínico-laboratoriales. Se hace una valoración de los tratamientos sustitutivos y profilácticos. Se expone el estudio de tres casos clínicos observados en el lapso de 30 años de práctica dermatológica.


Sujets)
Humains , Mâle , Femelle , Adulte , Angioedème/génétique , /administration et posologie , /usage thérapeutique , Androgènes/usage thérapeutique , Angioedème/complications , Angioedème/physiopathologie , Kallicréines/effets indésirables , Kallicréines/physiologie , Cinnarizine/administration et posologie , Cinnarizine/usage thérapeutique , Complément C1s , Complément C1s/déficit , Protéines du système du complément , Diagnostic différentiel , Code génétique , Kinines/effets indésirables , Plasma sanguin , Pronostic , Stanozolol/administration et posologie , Stanozolol/usage thérapeutique , Suramine/administration et posologie , Suramine/usage thérapeutique
6.
non conventionnel Dans Espagnol | LILACS | ID: lil-113241

Résumé

Revisa avances producidos entre 1980 y 1983 -como reultado de la actividad del Subprograma de Enfermedad de Chagas, del Programa Nacional de Enfermedades Endémicas (Argentina)-, sobre bioquímica del Trypanosoma cruzi y quimioterapia de la Enfermedad de Chagas: Composición química del T. cruzi (glicoconjugados, lípidos, ácidos nucleicos); metabolismo de carbohidratos (biosíntesis de glicoconjugados, fermentación aeróbica de la glucosa, alfa-hidroxiácido dehidrogenasa); mecanismos de conservación de energía: transporte de electrones y fosforilación oxidativa; catabolismo de proteínas y aminoácidos (proteaseas, glutamato dehidrogenasa); métodos bioquímicos aplicados a la caracterización de poblaciones del T. cruzi (zimograma electroforético, DNA nuclear y cintoplástico); efectos químicos de drogas tripanocidas: Nifurtimox, Benznidazol y 3-lapachona, gossipol, suramina; y, síntesis de nuevos compuestos tripanocidas


Sujets)
Animaux , Glucides/métabolisme , Maladie de Chagas/traitement médicamenteux , ADN , Transport d'électrons , Enzymes/métabolisme , Glutamate dehydrogenase/métabolisme , Gossypol/usage thérapeutique , Mitochondries , Nifurtimox/usage thérapeutique , Nitroimidazoles/usage thérapeutique , Phosphorylation oxydative , Peptide hydrolases/métabolisme , Suramine/usage thérapeutique , Trypanosoma cruzi/analyse , Trypanosoma cruzi/effets des médicaments et des substances chimiques , Trypanosoma cruzi/isolement et purification , Trypanosoma cruzi/métabolisme
SÉLECTION CITATIONS
Détails de la recherche